• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec8
Distribution Plan(CST)

Cash dividend 0.189 CNY

Dec6
Distribution Plan(CST)

Cash dividend 0.189 CNY

Distribution Plan(CST)

Cash dividend 0.189 CNY

View More

Event Tracking

Dec29
Hengrui Medicine Subsidiary Obtains Clinical Trial Approval for HRS-6257
10:01
Dec28
Huahai Pharmaceutical and Shanghai Huahai's SHR-A1904 Injection Listed as Breakthrough Therapy
10:24
Hengrui Medicine Subsidiary Entrusts Hansoh Pharmaceutical for Palocabigine Soft Capsule Commercialization
08:39
Dec24
Hengrui Medicine’s SHR-A1904 Injection Included in Breakthrough Therapy List
08:56
Hengrui Medicine Subsidiary's SHR-A2102 Receives Clinical Trial Approval from NMPA
08:47
Dec23
BlackRock Reduces Stake in WuXi Biologics
09:08